InMed Pharmaceuticals Inc. (INM) Insider Trading

Name: InMed Pharmaceuticals Inc. (INM) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 16, 2026): ADAR1 Capital Management, LLC (10% Owner): Purchase of 28,505 shares, $36.9K.

Get alerted when insiders trade INM

Email address

Loading company data...

Beta

Loading company details...

Beta